Chromium picolinate/inulin Interactions
There are 82 drugs known to interact with chromium picolinate/inulin, along with 4 disease interactions. Of the total drug interactions, 1 is major, 80 are moderate, and 1 is minor.
- View all 82 medications that may interact with chromium picolinate/inulin
- View chromium picolinate/inulin disease interactions (4)
Most frequently checked interactions
View interaction reports for chromium picolinate / inulin and the medicines listed below.
- Advil (ibuprofen)
- Aleve (naproxen)
- Calamine Plain (calamine topical)
- Celebrex (celecoxib)
- Choline Magnesium Trisalicylate (choline salicylate / magnesium salicylate)
- Chromium GTF (chromium picolinate)
- Colace (docusate)
- Copper (copper gluconate)
- CoQ10 (ubiquinone)
- D3 (cholecalciferol)
- Ester-C (ascorbic acid)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flax Seed Oil (flax)
- Flextra (acetaminophen / caffeine / phenyltoloxamine)
- Gardasil 9 (human papillomavirus vaccine)
- Iron Fumarate (ferrous fumarate)
- Iron Gluconate (ferrous gluconate)
- Iron Sulfate (ferrous sulfate)
- Omega-3 (omega-3 polyunsaturated fatty acids)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Synthroid (levothyroxine)
- Tylenol (acetaminophen)
- Vitamin B Complex 100 (multivitamin)
- Vitamin B1 (thiamine)
- Vitamin B12 (cyanocobalamin)
- Vitamin B2 (riboflavin)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vitamin K1 (phytonadione)
Chromium picolinate/inulin disease interactions
There are 4 disease interactions with chromium picolinate / inulin which include:
- inflammatory bowel disease
- intestinal obstruction disorders
- renal dysfunction
- malabsorption syndromes
Report options
QR code containing a link to this page
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.